In a syngeneic transplantation tumor model of murine CRC CT26 cells, CXCL4 could be induced by fluorouracil (5-FU) treatment in CRC cells, inhibiting the function of CTLs, and promoting tumor growth in mice [70]. The gene discussed is PF4; the disease is neoplasm.